The effect of Farnesoid X receptor agonist tropifexor on liver damage in rats with experimental obstructive jaundice
Kilavuz, Huseyin; Turan, Umit; Yoldas, Atilla; Tolun, Fatma Inanc; Tanriverdi, Burak; Yaylali, Asli; Yaman, Abit; Yener, Mehmet Kemal; Irkorucu, Oktay.
Acta cir. bras;
36(9): e360902, 2021. tab, graf
Artigo
em Inglês
| LILACS
| ID: biblio-1345027
Resumo
ABSTRACT Purpose: To investigate experimentally the effects of Tropifexor, a farnesoid X receptor agonist, on liver injury in rats with obstructive jaundice. Methods: Forty healthy Wistar albino female rats were divided randomly in selected groups. These groups were the sham group, control group, vehicle solution group, Ursodeoxycholic acid group and Tropifexor group. Experimental obstructive jaundice was created in all groups, except the sham one. In the blood samples obtained, aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), total bilirubin and direct bilirubin levels were established and recorded. Additionally, liver malondialdehyde, myeloperoxidase and catalase enzyme activity in the tissue samples were studied. Histopathological analysis was also performed. Results: No statistical difference was found between the control group and the Tropifexor group when AST, ALT and ALP values were compared. However, it was found that the Tropifexor group had statistically significant decreases in the values of GGT, total bilirubin and direct bilirubin (p < 0.05). Additionally, Tropifexor decreased the median values of malondialdehyde and myeloperoxidase, but this difference was not statistically significant compared to the control group. Finally, the Tropifexor group was statistically significant in recurring histopathological liver damage indicators (p < 0.05). Conclusions: Tropifexor reduced liver damage due to obstructive jaundice.
Biblioteca responsável:
BR1.1
Texto completo